Beta Drugs (India) Technical Analysis
| BETA Stock | 1,925 75.05 4.06% |
As of the 24th of March, Beta Drugs shows the Mean Deviation of 2.96, standard deviation of 3.91, and insignificant Risk Adjusted Performance. Our technical analysis interface gives you tools to check existing technical drivers of Beta Drugs, as well as the relationship between them. Please confirm Beta Drugs mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Beta Drugs is priced correctly, providing market reflects its regular price of 1925.05 per share.
Beta Drugs Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Beta, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BetaBeta |
Beta Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Beta Drugs Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Beta Drugs volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Beta Drugs Trend Analysis
Use this graph to draw trend lines for Beta Drugs. You can use it to identify possible trend reversals for Beta Drugs as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Beta Drugs price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Beta Drugs Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Beta Drugs applied against its price change over selected period. The best fit line has a slop of 5.11 , which may suggest that Beta Drugs market price will keep on failing further. It has 122 observation points and a regression sum of squares at 986938.34, which is the sum of squared deviations for the predicted Beta Drugs price change compared to its average price change.About Beta Drugs Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Beta Drugs on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Beta Drugs based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Beta Drugs price pattern first instead of the macroeconomic environment surrounding Beta Drugs. By analyzing Beta Drugs's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Beta Drugs's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Beta Drugs specific price patterns or momentum indicators. Please read more on our technical analysis page.
Beta Drugs March 24, 2025 Technical Indicators
Most technical analysis of Beta help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Beta from various momentum indicators to cycle indicators. When you analyze Beta charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.58) | |||
| Mean Deviation | 2.96 | |||
| Coefficient Of Variation | (8,236) | |||
| Standard Deviation | 3.91 | |||
| Variance | 15.3 | |||
| Information Ratio | 0.0025 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | 0.2396 | |||
| Treynor Ratio | (0.59) | |||
| Maximum Drawdown | 16.49 | |||
| Value At Risk | (4.93) | |||
| Potential Upside | 9.3 | |||
| Skewness | 0.8095 | |||
| Kurtosis | 1.52 |
Beta Drugs March 24, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Beta stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 0.63 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 1,880 | ||
| Day Typical Price | 1,895 | ||
| Price Action Indicator | 82.57 | ||
| Market Facilitation Index | 120.00 |
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.